.
Schema-Root.org logo

 

  cross-referenced news and research resources about

 Merck

images:  google   yahoo

Sun. November 08, 2009

-
The Dow Jones Industrial Average was recently up 119 points, or 1.2%, at 9891.39, led by a 6% surge in component Merck. The drug maker said it expects ...
The vaccine is different from the Merck's
Is the new Merck
Shares of Merck

Find out why shares of Merck
Non-GAAP results for fiscal 2009 exclude the recognition of previously deferred revenue totaling approximately $35 million, in connection with Merck
The $41 billion Merck
Merck
Merck
Merck
And like Pfizer Inc., Merck
NuevolutionA/S today announced that it has received a milestone payment derived from its collaboration with Merck
The companies say Merck's
Ms. McGlynn most recently served as President of Vaccines and Infectious diseases for Merck
As previously announced, the combined company will be known as Merck
We have known Merck
Merck has agreed to sell its interest in Merial Ltd, an animal health business, to its French partner in the joint venture, Sanofi-Aventis (SASY. ...
Merck
The company signed an agreement with Merck Chimie SAS ("Merck") in January pursuant to which Merck is further developing the Beads and will distribute the ...
Since then, Merck has returned 16.9% as of today's recent price of $32.72. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE ...
Pfizer (nyse: PFE) closed its acquisition of Wyeth earlier this month and the EU signed off on Merck's (NYSE: MRK) acquisition of ...
Press, 2008), and her research on STI stigma provides insight into the negative health consequences of Merck's original campaign for developing and ...
An early-stage hepatitis C program is fully funded by Merck. "Metabasis has built a pipeline of product candidates and drug development programs that have ...
... Inc. (NYSE:KG) announced that it has licensed the exclusive rights to market and sell CYANOKIT from Merck Sante SAS CYANOKIT is used for the treatment ...
investors suing Merck over Vioxx got a boost from the White House yesterday. In an amicus curiae brief filed with the Supreme Court, ...
"We are pleased to celebrate success in reaching another milestone with our valued partner, Merck," said Yves Ribeill, Ph.D., President and Chief Executive ...
FRANKFURT (MarketWatch) -- German pharmaceutical and chemical company Merck KGaA (FRANKFURT:DE:MRK) was downgraded Tuesday to hold from buy at Royal Bank of ...
As a reminder, Merck filed for EU approval last month after the completion of the sale of its 50% interest in animal health company Merial Limited (Merial) ...
AP Writer BRUSSELS (AP) - The European Union approved Merck & Co.'s proposed takeover of Schering-Plough, which would create the second-biggest global ...
investors are seeking billions of dollars in damages from Merck. They filed the first of several securities lawsuits against the Whitehouse Station, ...
Richard Clark, chairman, president and CEO of Merck, said: "Growth of key products, Januvia, Janumet, Isentress and Singulair, plus continued expense ...
This opportunity is available only to Merck and Co., Inc. under Contract Number 200-2009-30523 which was previously competed and awarded in fiscal year 2009 ...
NSBNEWS.net provides around the clock news, features, and commentary for the Southeast Volusia communities of New Smyrna Beach, Edgewater, Oak Hill, ...
2009-10-26 10:06:59 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Merck KGaA and produced a report, rating the company's ...
During morning trading, options volume in Merck & Co. Inc. (MRK) suggests an investor rolled a long call position in the front-month out to ...
On the downside, shares of German pharmaceutical and chemical company Merck KGaA (FRANKFURT:DE:MRK) fell 4%. Third-quarter net income fell 28% from the ...
DARMSTADT, Germany, Oct 26 (Reuters) - Merck KGaA's (MRCG.DE) 2009 outlook fell short of market expectations on monday as the ...
BRUSSELS, Oct 23 - US. drugmaker Merck & Co Inc's $41.1 billion takeover of smaller rival Schering-Plough Corp won approval from European Union antitrust ...
Merck and Schering-Plough hope they will form a strong unit capable of growing over time while maximizing shareholder value. That remains to be seen. ...
Integration planning teams from Merck and Schering-Plough are working together to ensure that the combined company will be well equipped to begin its first ...


 


schema-root.org

     merck

pharmaceutical manufacturers:
     astrazeneca
     baxter
     eli lilly
     glaxosmithkline
     merck
     novartis
     pfizer
     research
     takeda
     upjohn

page tools:

short url:
http://schema-root.org/p/2553

Send link to a friend

Google cache of page


schemata ©2009 John Tinker